Stay updated on Granix Disruption in Myeloma Transplant Clinical Trial
Sign up to get notified when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.

Latest updates to the Granix Disruption in Myeloma Transplant Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations were added to the page, including Missouri, indicating where the study is conducted. A related location entry and certain footer items were removed.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page removes the 'Multiple Myeloma' entry and the related topics section 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a related topic link to MedlinePlus Genetics and updated the page revision to v3.3.2.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page no longer displays the government funding notice and related topics (Multiple Myeloma and MedlinePlus Genetics). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedAdded mentions of multiple myeloma as the disease context and expanded sponsor/affiliation details (Washington University School of Medicine and Alvin J. Siteman Cancer Center), along with related topic links such as MedlinePlus Genetics.SummaryDifference0.8%

- Check69 days agoChange DetectedSponsor/institution names and the 'Helpful Links Provided by' section were removed, reducing explicit attribution and related context for the study.SummaryDifference0.2%

Stay in the know with updates to Granix Disruption in Myeloma Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.